Matthew Pavao


I immensely enjoy helping companies and institutions translate ground-breaking scientific innovations into strong, creative and dynamic intellectual property assets to gain a competitive edge, maximize revenue and meet long-term business objectives.

Dr. Matthew Pavao advises public and private companies, including early stage companies, as well as research and educational institutions, on all aspects of intellectual property to maximize revenue and meet their business objectives.

Download full bio 


  • Poseida Therapeutics Enters Strategic Collaboration and License Agreement With Roche 

  • Reata Pharmaceuticals – $505 Million Follow-On Offering 

  • ERYTECH – $144 Million IPO 

  • Selecta Biosciences – $74 Million IPO 

  • Inotek Pharmaceuticals – $50 Million Follow-On 

  • View all

Matthew provides helpful, well thought-out counsel. He is extremely practical and very creative. – Chambers USA 2021

  • Suffolk University
    JD, magna cum laude, 2006

  • Boston University
    PhD, Biochemistry

  • Boston University
    MA, Medical Sciences

  • University of Massachusetts
    BS, Biology, Zoology
    cum laude, 1993

Admissions & Credentials


U.S. Patent and Trademark Office


  • Boston Patent Law Association

  • American Intellectual Property Law Association

Rankings & Accolades

    Chambers: Leading Patent Lawyer 

    IAM Patent 1000: Top Patent Lawyer

    Super Lawyers: Leading IP Lawyer